Skip to main content
COLLEGIUM PHARMACEUTICAL, INC logo

COLLEGIUM PHARMACEUTICAL, INC — Investor Relations & Filings

Ticker · COLL ISIN · US19459J1043 LEI · 54930049FXZMTLW8D496 US Manufacturing
Open in API
Filings indexed 821 across all filing types
Latest filing 2020-02-27 Regulatory Filings
Country US United States of America
Listing US COLL

About COLLEGIUM PHARMACEUTICAL, INC

https://www.collegiumpharma.com/

Collegium Pharmaceutical, Inc. is a diversified biopharmaceutical company that develops and commercializes medicines for people with serious medical conditions. The company is focused on building a portfolio of differentiated medications. Its primary area of expertise is in pain management, where it develops products with abuse-deterrent properties designed to be safer alternatives for patients and the community.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text specifically states that the company issued a press release announcing its financial results for the quarterly period and fiscal year ended December 31, 2019, and that the press release is attached as Exhibit 99.1. The document itself does not contain the full financial results or detailed financial statements but rather furnishes the press release. The length is 6780 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, if a document is short and states that a report or press release is attached or furnished, it should be classified as a Regulatory Filing (RNS) rather than the actual Earnings Release (ER) or Annual Report (10-K). Therefore, this document is best classified as a Regulatory Filing (RNS).
2020-02-27 English
PRIMARY DOCUMENT
Major Shareholding Notification
2020-02-21 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes details about the issuance of convertible senior notes, the completion of an acquisition, entry into material definitive agreements, and related financing activities. It also mentions transaction bonuses to executives and a press release about the acquisition closing. The document is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a transcript, proxy statement, or governance report. It primarily provides updates on capital raising and financing activities related to the issuance of convertible notes and a secured term loan. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2020-02-13 English
JANUS HENDERSON GROUP PLC OWNS 13.4% OF COLLEGIUM
Major Shareholding Notification
2020-02-13 English
SC 13G/A
Major Shareholding Notification
2020-02-13 English
SC 13G/A
Major Shareholding Notification
2020-02-13 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.